Allogene Therapeutics Inc (ALLO)
Who owns Allogene Therapeutics Inc (ALLO)? This page shows the largest institutions and funds, the ownership structure and the latest insider transactions. 78.4% of the shares are freely tradable; institutional investors hold 53.3%.
Ownership Structure
Largest Shareholders
Institutions
| Name | Stake (%) | Shares | Change (%) | Date |
|---|---|---|---|---|
| Pfizer Inc | 6.38 | 22,032,040 | +0.0 | 03/31/2026 |
| BlackRock Inc | 5.53 | 19,091,095 | +8.0 | 03/31/2026 |
| TPG GP A, LLC | 5.42 | 18,716,306 | +0.0 | 03/31/2026 |
| Vanguard Group Inc | 2.68 | 9,251,609 | +2.6 | 12/31/2025 |
| State Street Corp | 2.51 | 8,660,306 | +213.6 | 03/31/2026 |
| PRIMECAP Management Company | 2.43 | 8,379,840 | +2.9 | 03/31/2026 |
| Vanguard Capital Management, LLC | 2.01 | 6,921,350 | +0.0 | 03/31/2026 |
| Citadel Advisors Llc | 1.97 | 6,793,620 | -43.9 | 03/31/2026 |
Funds
| Name | Stake (%) | Shares | Change (%) | Date |
|---|---|---|---|---|
| Fidelity Select Biotechnology | 2.56 | 8,829,193 | +530.2 | 04/30/2026 |
| Vanguard Total Stock Mkt Idx Inv | 2.44 | 8,427,791 | +72.7 | 04/30/2026 |
Largest reported positions according to regulatory filings; stake as a percentage of shares outstanding, change versus the previous filing. Source: fundamentals data.
Insider Transactions
| Date | Person | Role | Type | Shares | Price | Value |
|---|---|---|---|---|---|---|
| 21. Apr 2026 | Annie Yoshiyama | SVP | Sell | 9,586 | 2.31 | 22,144 |
Reportable transactions by officers and major shareholders from SEC Form 4 filings. "Other" includes things like stock grants and option exercises without a buy/sell character.
View all insider transactions →Data as of: July 31, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.